- New
1. Formulation
(a) Each tablet contains 35 mg of trimetazidine.
(b) It comes in a modified-release formulation, taken orally twice daily.
2. Indications
(a) RITEMED Trimetazidine is indicated for:
o Stable angina pectoris (chest pain due to coronary disease).
o Long-term treatment of coronary insufficiency.
3. Contraindications
(a) Avoid in cases of:
o Hypersensitivity to trimetazidine or its components.
o Parkinson's disease or related movement disorders.
o Severe renal impairment (creatinine clearance <30 mL/min).
o Pregnancy.
Customers who bought this product also bought:
RITEMED Trimetazidine is a medication used for the symptomatic treatment of stable angina pectoris. It helps protect heart cells during episodes of angina by improving oxygen supply.